UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

OnabotulinumtoxinA versus IncobotulinumtoxinA in the treatment of patients with idiopathic or neurogenic detrusor overactivity: A prospective, randomized study

European urology open science (Online), 2020-07, Vol.19, p.e807-e808

2020

Volltextzugriff (PDF)

Intravesical electromotive mitomycin for primary high risk non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin failure: A single arm phase II multicenter prospective study

European urology, 2024-03, Vol.85, p.S1697

2024

Volltextzugriff (PDF)

A0728 - Intravesical electromotive mitomycin for primary high risk non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin failure: A single arm phase II multicenter prospective study

European urology, 2024-03, Vol.85, p.S1697-S1697

2024

Volltextzugriff (PDF)

945 Is intravesical BCG alone still the only truly effective intravesical therapy for high risk nonmuscle invasive bladder cancer?

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e945-e945

2015

Volltextzugriff (PDF)

698 Intravesical sequential BCG and electromotive mitomycin versus BCG alone for stage pT1 urothelial bladder cancer

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e698-e699

2013

Volltextzugriff (PDF)

Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease

BJU international, 2003-06, Vol.91 (9), p.825-829

2003

Volltextzugriff (PDF)

1045 Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e1045-e1045a

2012

Volltextzugriff (PDF)

196 SIGLE IMMEDIATE PREOPERATIVE INTRAVESICAL INSTILLATION OF ELECTROMOTIVE MITOMYCIN-C FOR PRIMARY NON-MUSCLE INVASIVE BLADDER CANCER: A RANDOMIZED PROSPECTIVE TRIAL

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.93-93

2010

Volltextzugriff (PDF)

197 CONCENTRATION-DEPTH PROFILES OF MITOMYCIN-C IN THE HUMAN BLADDER WALL AFTER PASSIVE DIFFUSION, THERMO-CHEMOTHERAPY AND ELECTROMOTIVE DRUG ADMINISTRATION

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.93-94

2010

Volltextzugriff (PDF)

651 IMMUNOTHERAPY OR CHEMOTHERAPY AS LOCAL THERAPY OF URINARY BLADDER CANCER – WHICH IS THE MOST EFFECTIVE? REPORT ON A META-ANALYSIS OF THE LONG-TERM OUTCOME OF RANDOMIZED STUDIES COMPARING INTRAVESICAL MITOMYCIN C VERSUS BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE BLADDER CANCER

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.283-283

2009

Volltextzugriff (PDF)

CARCINOMA IN SITU OF THE BLADDER: LONG-TERM RESULTS OF A RANDOMISED PROSPECTIVE STUDY COMPARING INTRAVESICAL ELECTROMOTIVE MITOMYCIN-C, PASSIVE DIFFUSION MITOMYCIN-C AND BACILLUS CALMETTE-GUERIN

European urology supplements : official journal of the European Association of Urology, 2008, Vol.7 (3), p.180-180

2008

Volltextzugriff (PDF)

895 INTRAVESICAL PASSIVE DELIVERY OF BOTULINUM A TOXIN IN PATIENTS AFFECTED BY PAINFUL BLADDER SYNDROME: A PILOT STUDY

European urology supplements : official journal of the European Association of Urology, 2007, Vol.6 (2), p.246-246

2007

Volltextzugriff (PDF)

T01-O-09 In vivo measurement of the human G-spot

Sexologies : European journal of sexology, 2008-04, Vol.17, p.S52-S53

2008

Volltextzugriff (PDF)

Urological Dysfunctions and Upper Urinary Tract Involvement in Multiple Sclerosis Patients

The Journal of urology, 1999-09, Vol.162 (3), p.968-968

1999

Volltextzugriff (PDF)

153 O - In vitro electromotive administration of mitomycin C in human bladder wall

European journal of cancer (1990), 1996, Vol.32, p.S30-S30

1996

Volltextzugriff (PDF)

4-31-10 Urological dysfunctions and upper urinary tract involvement in multiple sclerosis (MS) patients

Journal of the neurological sciences, 1997-09, Vol.150, p.S249-S250

1997

Volltextzugriff (PDF)

2-52-13 Treatment of neurogenic bladder in spinal cord injury (SCI) patients by means of clean intermittent catheterization (CIC): Prevention of renal disease

Journal of the neurological sciences, 1997-09, Vol.150, p.S134-S134

1997

Volltextzugriff (PDF)

BOTULINUM A TOXIN INTRAVESICAL INJECTIONS IN THE TREATMENT OF PAINFUL BLADDER SYNDROME: A PILOT STUDY

European urology supplements : official journal of the European Association of Urology, 2006-04, Vol.5 (2), p.118-118

2006

Volltextzugriff (PDF)

815Nerve growth factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor over activity treated with tamsulosin

European urology supplements : official journal of the European Association of Urology, 2005-03, Vol.4 (3), p.206-206

2005

Volltextzugriff (PDF)

RADICAL RETROPUBIC PROSTATECTOMY VERSUS EXTERNAL BEAM RADIOTHERAPY FOR LOCALISED PROSTATE CANCER: AN INTERIM REPORT OF A MULTICENTRE, PROSPECTIVE, PHASE III RANDOMISED STUDY

European urology supplements : official journal of the European Association of Urology, 2006-04, Vol.5 (2), p.204-204

2006

Volltextzugriff (PDF)

LONG-TERM FOLLOW-UP OF A RANDOMISED TRIAL COMPARING SEQUENTIAL BACILLUS CALMETTE-GUÈRIN AND ELECTROMOTIVE MITOMYCIN-C WITH BACILLUS CALMETTE GUÈRIN ALONE IN HIGH-RISK SUPERFICIAL BLADDER CANCER

European urology supplements : official journal of the European Association of Urology, 2006-04, Vol.5 (2), p.191-191

2006

Volltextzugriff (PDF)

489 Sequential intravesical bacillus Calmette-Guèrin and electromotive mitomycin-C for high risk superficial bladder cancer: A prospective controlled study

European urology supplements : official journal of the European Association of Urology, 2004-02, Vol.3 (2), p.125-125

2004

Volltextzugriff (PDF)

301General and disease specific health related quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: A controlled prospective study

European urology supplements : official journal of the European Association of Urology, 2005-03, Vol.4 (3), p.78-78

2005

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(9)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Urology
(8)
Administration, Cutaneous
(1)
Adult
(1)
Aged
(1)
Biological And Medical Sciences
(1)
Dexamethasone
(1)
Dexamethasone - Administration & Dosage
(1)
Drug Combinations
(1)
Electric Current
(1)
Erectile Dysfunction - Prevention & Control
(1)
Genital System. Reproduction
(1)
Humans
(1)
Iontophoresis - Methods
(1)
Life Sciences & Biomedicine
(1)
Male
(1)
Medical Sciences
(1)
Middle Aged
(1)
Pain - Etiology
(1)
Patient Satisfaction
(1)
Penile Induration - Drug Therapy
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

OnabotulinumtoxinA versus IncobotulinumtoxinA in the treatment of patients with idiopathic or neurogenic detrusor overactivity: A prospective, randomized study

Intravesical electromotive mitomycin for primary high risk non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin failure: A single arm phase II multicenter prospective study

A0728 - Intravesical electromotive mitomycin for primary high risk non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin failure: A single arm phase II multicenter prospective study

945 Is intravesical BCG alone still the only truly effective intravesical therapy for high risk nonmuscle invasive bladder cancer?

698 Intravesical sequential BCG and electromotive mitomycin versus BCG alone for stage pT1 urothelial bladder cancer

Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease

1045 Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial

196 SIGLE IMMEDIATE PREOPERATIVE INTRAVESICAL INSTILLATION OF ELECTROMOTIVE MITOMYCIN-C FOR PRIMARY NON-MUSCLE INVASIVE BLADDER CANCER: A RANDOMIZED PROSPECTIVE TRIAL

197 CONCENTRATION-DEPTH PROFILES OF MITOMYCIN-C IN THE HUMAN BLADDER WALL AFTER PASSIVE DIFFUSION, THERMO-CHEMOTHERAPY AND ELECTROMOTIVE DRUG ADMINISTRATION

651 IMMUNOTHERAPY OR CHEMOTHERAPY AS LOCAL THERAPY OF URINARY BLADDER CANCER – WHICH IS THE MOST EFFECTIVE? REPORT ON A META-ANALYSIS OF THE LONG-TERM OUTCOME OF RANDOMIZED STUDIES COMPARING INTRAVESICAL MITOMYCIN C VERSUS BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE BLADDER CANCER

CARCINOMA IN SITU OF THE BLADDER: LONG-TERM RESULTS OF A RANDOMISED PROSPECTIVE STUDY COMPARING INTRAVESICAL ELECTROMOTIVE MITOMYCIN-C, PASSIVE DIFFUSION MITOMYCIN-C AND BACILLUS CALMETTE-GUERIN

895 INTRAVESICAL PASSIVE DELIVERY OF BOTULINUM A TOXIN IN PATIENTS AFFECTED BY PAINFUL BLADDER SYNDROME: A PILOT STUDY

T01-O-09 In vivo measurement of the human G-spot

Urological Dysfunctions and Upper Urinary Tract Involvement in Multiple Sclerosis Patients

153 O - In vitro electromotive administration of mitomycin C in human bladder wall

4-31-10 Urological dysfunctions and upper urinary tract involvement in multiple sclerosis (MS) patients

2-52-13 Treatment of neurogenic bladder in spinal cord injury (SCI) patients by means of clean intermittent catheterization (CIC): Prevention of renal disease

BOTULINUM A TOXIN INTRAVESICAL INJECTIONS IN THE TREATMENT OF PAINFUL BLADDER SYNDROME: A PILOT STUDY

815Nerve growth factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor over activity treated with tamsulosin

RADICAL RETROPUBIC PROSTATECTOMY VERSUS EXTERNAL BEAM RADIOTHERAPY FOR LOCALISED PROSTATE CANCER: AN INTERIM REPORT OF A MULTICENTRE, PROSPECTIVE, PHASE III RANDOMISED STUDY

LONG-TERM FOLLOW-UP OF A RANDOMISED TRIAL COMPARING SEQUENTIAL BACILLUS CALMETTE-GUÈRIN AND ELECTROMOTIVE MITOMYCIN-C WITH BACILLUS CALMETTE GUÈRIN ALONE IN HIGH-RISK SUPERFICIAL BLADDER CANCER

489 Sequential intravesical bacillus Calmette-Guèrin and electromotive mitomycin-C for high risk superficial bladder cancer: A prospective controlled study

301General and disease specific health related quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: A controlled prospective study

Suchergebnisse filtern